The solid lipid nanoparticles encapsulated polyoxometalate K6[γ-(CpTi)2SiW10O38] (abbreviated as (CpTi)2 SiW10 Cp=η5-C5H5) have been prepared and structurally characterized by elemental ananlysis, IR, UV spectroscop...The solid lipid nanoparticles encapsulated polyoxometalate K6[γ-(CpTi)2SiW10O38] (abbreviated as (CpTi)2 SiW10 Cp=η5-C5H5) have been prepared and structurally characterized by elemental ananlysis, IR, UV spectroscopy and TEM. The result showed that the polyoxometalate retained the parent structure after being encapsulated and the encapsulation increased the antitumoral activity of the polyoxometalate.展开更多
文摘The solid lipid nanoparticles encapsulated polyoxometalate K6[γ-(CpTi)2SiW10O38] (abbreviated as (CpTi)2 SiW10 Cp=η5-C5H5) have been prepared and structurally characterized by elemental ananlysis, IR, UV spectroscopy and TEM. The result showed that the polyoxometalate retained the parent structure after being encapsulated and the encapsulation increased the antitumoral activity of the polyoxometalate.